Authors' Reply to Moura et al.: 'Safety of Janus Kinase Inhibitors in Older Patients: A Focus on the Thromboembolic Risk'

Autor:	Omer Nuri Pamuk, James D. Katz, Suraj Rajasimhan
Rok vydání:	2021
Předmět:	medicine.medical_specialty Focus (computing) Geriatrics gerontology business.industry Pharmacology toxicology Thromboembolic risk Pharmacotherapy Older patients Thromboembolism medicine Humans Janus Kinase Inhibitors Pharmacology (medical) Geriatrics and Gerontology Janus kinase Intensive care medicine business Aged
Zdroj:	Drugsaging. 38(6)
ISSN:	1179-1969
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e7ab827e5df5be0e736599b0bc91409f https://pubmed.ncbi.nlm.nih.gov/33871804 Zobrazit plný text záznamu Full text from SpringerLink